Bright Minds Biosciences Inc (DRUG) — Cash Flow Quality Index

Latest as of December 2024: -30.12x

Bright Minds Biosciences Inc (DRUG) has a Cash Flow Quality Index of -30.12x as of December 2024. Operating cash flow of $-1.49 Million is below net income of $49.61K, suggesting accrual-heavy earnings not yet converted to cash. Explore Bright Minds Biosciences Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-30.12x

Operating CF / Net Income

Operating Cash Flow

$-1.49 Million

USD

Net Income

$49.61K

USD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for Bright Minds Biosciences Inc (None–None)

Year-by-year earnings quality comparison for Bright Minds Biosciences Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.